Yarrow Bioscience, Inc. (YARW)
Yarrow Bioscience is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. The Company's lead product candidate, YB-101, is a potential first-in-class anti-thyroid stimulating hormone receptor (TSHR) monoclonal antibody designed to directly and rapidly disrupt the central mechanism of both Graves' disease (GD) and thyroid eye disease (TED).
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Yarrow Bioscience Inc
NASDAQ:YARWHealthcare · Biotechnology
-0.50%$19.90
AH$19.90+0.00%vs close
Mkt Cap$185.16M
Float9.3M
O/S9.3M
Vol
$ Vol
RVOL
Inst Own2.9%
Earnings
Div Yield101.00%
Dilution
Financials Summary
Revenue$570K
Net Income-$26.48M
Total Assets$30.16M
Free Cash Flow-$33.12M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$27.77M
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
2-year cumulative
1:2,500Over cap
Past the 1:250 Nasdaq cap, ineligible for a bid-price compliance period
- 1:50Reverse splitJul 27, 202650 shares → 1
- 1:50Reverse splitJul 27, 202650 shares → 1
Balance Sheet Details
Assets$30.16M
Liabilities$2.4M
Accounts Receivable$0
Accounts Payable$1.04M
Inventory$0
PP&E (Net)$90K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Revenue | $570K | $501K | $424K | $477K | $931K | $20.99M | $443K | $10.64M | $4.58M | $674K | $0 |
| YoY Growth | 13.8% | 18.2% | -11.1% | -48.8% | -95.6% | 4638.8% | -95.8% | 132.2% | 579.8% | - | - |
| Cost of Revenue | $23K | $0 | $0 | $0 | $0 | $1.39M | $350K | $0 | $0 | $0 | $0 |
| Gross Profit | $547K | $501K | $424K | $477K | $931K | $19.6M | $93K | $10.64M | $4.58M | $674K | $0 |
| Gross Margin | 96.0% | 100.0% | 100.0% | 100.0% | 100.0% | 93.4% | 21.0% | 100.0% | 100.0% | 100.0% | - |
| Research and Development | $19.24M | $30.95M | $16.31M | $18.39M | $19.54M | $43.53M | $53.76M | $52.99M | $29.01M | $11.26M | $2.92M |
| Selling, General, and Administrative | $11.08M | $13.19M | $13.38M | $16.39M | $20.3M | $89.54M | $22.48M | $12.19M | $5.17M | $3.75M | $1.69M |
| Other | -$23K | $0 | $0 | $0 | $0 | -$366.02M | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $30.3M | $44.14M | $29.68M | $34.77M | $39.84M | -$232.94M | $76.24M | $65.17M | $34.17M | $15.01M | $4.61M |
| Operating Income (EBIT) | -$29.75M | -$43.64M | -$29.26M | -$34.3M | -$38.91M | $252.55M | -$76.24M | -$54.53M | -$29.59M | -$14.33M | -$4.61M |
| Operating Margin | -5219.1% | -8710.0% | -6900.5% | -7189.7% | -4179.5% | 1203.0% | -17210.4% | -512.5% | -645.9% | -2126.4% | - |
| Interest Expense | $0 | $0 | $0 | $0 | $5.61M | $4.39M | $921K | $0 | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.09M | $517K | $264K | $0 |
| Other Income (Expense) | $3.02M | $3.83M | $1.39M | $363K | -$4.85M | -$508.37M | -$19.11M | $3.09M | $517K | $264K | $0 |
| Income Before Tax (EBT) | -$26.73M | -$39.8M | -$27.87M | -$33.93M | -$43.76M | -$255.83M | -$73.7M | -$51.45M | -$29.08M | -$14.07M | -$4.61M |
| Income Tax Expense | $4K | $4K | $0 | $13K | $448K | -$258K | -$3.24M | $0 | -$8K | $0 | $0 |
| Net Income | -$26.48M | -$39.83M | -$28.45M | -$23.21M | -$73.33M | -$255.57M | -$70.46M | -$51.45M | -$29.08M | -$14.07M | -$4.61M |
| Net Income Margin | -4646.1% | -7950.9% | -6710.4% | -4865.8% | -7876.4% | -1217.4% | -15906.1% | -483.5% | -634.6% | -2087.2% | - |
| Supplementary Data | |||||||||||
| EPS | -30.96 | -46.77 | -138.48 | -566.98 | -1282.44 | -7095.17 | -10095.00 | -8546.98 | -4555.37 | -2204.06 | -774.18 |
| Diluted EPS | -30.96 | -46.77 | -138.48 | -566.98 | -1282.44 | -7095.17 | -10095.00 | -8546.98 | -4555.37 | -2204.06 | -774.18 |
| Weighted Average OS | 855,360 | 851,780 | 205,460 | 63,719 | 57,179 | 36,019 | 9,427 | 6,019 | 6,382 | 6,382 | 5,952 |
| EBITDA | -$26.71M | -$39.8M | -$27.87M | -$33.86M | -$38.04M | -$251.09M | -$94.08M | -$54.53M | -$29.59M | -$14.33M | -$4.61M |
| EBITDA Margin | -4685.8% | -7943.9% | -6573.6% | -7098.5% | -4086.0% | -1196.1% | -21237.7% | -512.5% | -645.9% | -2125.8% | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Assets | |||||||||||
| Current Assets | |||||||||||
| Cash and Cash Equivalents | $24.03M | $19.93M | $30.62M | $30.91M | $42.25M | $57.56M | $30.78M | $49.51M | $10.21M | $4.03M | $43.81M |
| Short-Term Investments | $4.98M | $41.59M | $62.63M | $0 | $0 | $1.03M | $46.17M | $86.74M | $49.3M | $26.88M | $0 |
| Cash and Short-Term Investments | $29.01M | $61.52M | $93.25M | $30.91M | $42.25M | $58.59M | $76.94M | $136.25M | $62.48M | $30.91M | $43.81M |
| Accounts Receivable | $0 | $0 | $0 | $5M | $7.58M | $15.82M | $0 | $0 | $786K | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $7.29M | $7.4M | $0 | $0 | -$2.98M | $0 | $0 |
| Other Current Assets | $1M | $2.92M | $2.71M | $240K | $1.5M | $855K | $0 | $3.25M | $0 | $0 | $0 |
| Total Current Assets | $30.01M | $64.44M | $95.96M | $38.27M | $63.19M | $87.26M | $78.33M | $139.5M | $63.86M | $31.54M | $43.88M |
| Long-Term Assets | |||||||||||
| Property, Plant & Equipment Net | $90K | $206K | $207K | $0 | $354K | $2.14M | $769K | $146K | $28K | $27K | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.98M | $10.42M | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $60K | $2.26M | $1.51M | $2.48M | $3.51M | $4.34M | $73K | $282K | $0 | $66K | $0 |
| Total Long-Term Assets | $150K | $2.47M | $1.72M | $2.48M | $3.86M | $6.48M | $842K | $428K | $3.01M | $10.51M | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $30.16M | $66.91M | $97.69M | $40.76M | $67.05M | $93.74M | $79.17M | $139.93M | $66.87M | $42.05M | $43.88M |
| Liabilities | |||||||||||
| Current Liabilities | |||||||||||
| Accounts Payable | $1.04M | $2.71M | $1.66M | $2.39M | $6.51M | $4.78M | $3.77M | $3.29M | $2.46M | $1.53M | $637K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.8M | $1.8M | $0 |
| Other Current Liabilities | $413K | $2.74M | $4.12M | $2.58M | $2.96M | $4.78M | $485K | $3.6M | $2.45M | $308K | $53K |
| Total Current Liabilities | $2.4M | $14.82M | $7.54M | $9.35M | $18.41M | $21.77M | $10.66M | $9.54M | $7.82M | $3.9M | $770K |
| Long-Term Liabilities | |||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $33.17M | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $6.74M | $8.53M | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $1.31M | $211K | $0 | $457K | $0 | $7K | $109.35M | $59.06M | $59.07M |
| Total Long-Term Liabilities | $0 | $0 | $1.41M | $211K | $0 | $34.48M | $0 | $7K | $116.08M | $67.59M | $59.07M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.4M | $14.82M | $8.95M | $9.56M | $18.41M | $56.25M | $10.66M | $9.55M | $123.9M | $71.49M | $59.84M |
| Stockholders' Equity | |||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $14.18M | $59M | $59M |
| Common Stock | $3K | $1K | $1K | $0 | $5K | $4K | $3K | $3K | $1K | $1K | $1K |
| Retained Earnings | -$757.65M | -$731.17M | -$691.34M | -$662.74M | -$639.52M | -$566.2M | -$184.34M | -$110.64M | -$59.19M | -$30.11M | -$16.05M |
| Comprehensive Income & Other | $2K | $20K | $26K | $0 | $0 | $0 | $24K | -$96K | -$51K | -$26K | -$59M |
| Other Stockholders' Equity | $785.41M | $783.25M | $780.07M | $693.94M | $688.16M | $603.68M | $252.84M | $241.01M | $2.16M | $673K | $93K |
| Total Equity | $27.77M | $52.09M | $88.73M | $31.2M | $48.64M | $37.49M | $68.51M | $130.38M | -$57.03M | -$29.44M | -$15.95M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $30.16M | $66.91M | $97.69M | $40.76M | $67.05M | $93.74M | $79.17M | $139.93M | $66.87M | $42.05M | $43.88M |
| Supplementary Data | |||||||||||
| Total Debt | $0 | $99K | $214K | $0 | $349K | $34.78M | $700K | $0 | $0 | $0 | $0 |
| Net Debt | -$24.03M | -$19.83M | -$30.41M | -$30.91M | -$41.9M | -$22.78M | -$30.08M | -$49.51M | -$10.21M | -$4.03M | -$43.81M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Operating Activities | |||||||||||
| Net Income | -$26.74M | -$39.83M | -$28.45M | -$23.21M | -$73.33M | -$255.57M | -$73.7M | -$51.45M | -$29.08M | -$14.07M | -$4.61M |
| Depreciation & Amortization | $23K | $4K | $0 | $72K | $109K | $341K | $350K | $22K | $8K | $4K | $0 |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $1.52M | $56.3M | $0 | $0 | $60K | -$573K | $0 |
| Stock-Based Compensation | $2.31M | $3.3M | $3.31M | $4.3M | $8.08M | $18.1M | $6.7M | $3.64M | $1.45M | $573K | $65K |
| Changes in Working Capital: | |||||||||||
| Accounts Receivable | $4.21M | -$899K | $405K | $11.21M | $7.71M | -$17.14M | $1.36M | $786K | -$786K | $0 | $0 |
| Inventory | $0 | $0 | $0 | $97K | $113K | -$6.05M | -$1.36M | $2.76M | $1.19M | $0 | $0 |
| Accounts Payable | -$12.31M | $6.01M | -$559K | -$8.68M | -$2.67M | -$12.97M | $481K | $825K | $620K | $889K | $0 |
| Other Working Capital | -$99K | -$114K | $214K | -$349K | -$371K | -$4.17M | $1.41M | -$8.55M | -$1.74M | $10.18M | $360K |
| Total Working Capital Change | -$8.19M | $5M | $60K | $2.28M | $4.78M | -$40.33M | $1.89M | -$4.17M | -$722K | $11.07M | $360K |
| Other Non-Cash Items | -$525K | -$2.44M | -$254K | -$12.64M | $2.47M | $84.07M | -$341K | -$774K | $31K | $705K | $65K |
| Net Cash from Operating | -$33.12M | -$33.97M | -$25.34M | -$29.2M | -$56.37M | -$137.08M | -$65.1M | -$52.73M | -$28.25M | -$2.29M | -$4.18M |
| Investing Activities | |||||||||||
| Capital Expenditures | $0 | -$117K | $0 | $0 | $0 | -$113K | -$11K | -$140K | -$27K | -$31K | $0 |
| Acquisitions | $0 | $0 | $5M | $15.67M | $0 | $38.64M | $40K | $0 | -$25K | $0 | $0 |
| Purchases of Investments | -$30.93M | -$60.52M | -$62.35M | $0 | $0 | -$38.64M | -$83.4M | -$126.7M | -$64.15M | -$55.31M | $0 |
| Sales of Investments | $68.3M | $84M | $0 | $0 | $1.03M | $50.58M | $124.78M | $92.96M | $49.11M | $17.85M | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $38.64M | -$40K | $0 | $25K | $0 | $0 |
| Net Cash from Investing | $37.37M | $23.36M | -$57.35M | $15.67M | $1.03M | $89.11M | $41.37M | -$33.88M | -$15.06M | -$37.49M | $0 |
| Financing Activities | |||||||||||
| Debt Repaid | - | - | - | - | $36.43M | - | - | - | - | - | - |
| Common Stock Issuance | -$143K | $0 | $82.82M | $1.47M | $75.98M | $61.64M | $4.53M | $125.42M | $50.32M | $0 | $47.72M |
| Common Stock Repurchases | $0 | -$141K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | -$67K | -$28K | $228K | $169K | $465K | $496K | -$833K | $0 | $98K |
| Net Cash from Financing | -$143K | -$141K | $82.39M | $1.65M | $39.78M | $61.81M | $4.99M | $125.91M | $49.49M | $0 | $47.72M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $1K | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $4.1M | -$10.75M | -$301K | -$11.88M | -$15.56M | $13.83M | -$18.73M | $39.3M | $6.18M | -$39.78M | $43.53M |
| Supplementary Data | |||||||||||
| Operating Cash Flow | -$33.12M | -$33.97M | -$25.34M | -$29.2M | -$56.37M | -$137.08M | -$65.1M | -$52.73M | -$28.25M | -$2.29M | -$4.18M |
| Capital Expenditure | $0 | -$117K | $0 | $0 | $0 | -$113K | -$11K | -$140K | -$27K | -$31K | $0 |
| Free Cash Flow | -$33.12M | -$34.09M | -$25.34M | -$29.2M | -$56.37M | -$137.19M | -$65.11M | -$52.87M | -$28.27M | -$2.32M | -$4.18M |
| Cash at Beginning | $19.93M | $30.67M | $30.98M | $42.85M | $58.42M | $44.58M | $49.51M | $10.21M | $4.03M | $43.81M | $273K |
| Cash at End | $24.03M | $19.93M | $30.67M | $30.98M | $42.85M | $58.42M | $30.78M | $49.51M | $10.21M | $4.03M | $43.81M |